Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer [NA]
Clinical trial update for focal salvage HDR brachytherapy in prostate cancer; the study remains active but not recruiting.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4) [NA]
Status update for the INTERVAL-GAP4 trial evaluating intense exercise for survival in men with metastatic prostate cancer. The study is curr…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy
This study investigates whether dynamic changes in dT-DNA levels in drainage fluid after radical prostatectomy can prognosticate outcomes in…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Prognostic Study of Via Dynamic Change of PCA3 mRNA in Drainage Fluid After Radical Prostatectomy
A prognostic clinical trial evaluating whether dynamic changes in PCA3 mRNA in drainage fluid after radical prostatectomy can predict outcom…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer [NA]
A pilot study evaluating whole-gland salvage HDR prostate brachytherapy for locally recurrent prostate cancer is currently active but not re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC [Phase 2]
Phase II randomized trial comparing patient-specific adaptive dosing versus continuous dosing of Abiraterone acetate or Enzalutamide for met…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) [Phase 2]
Phase 2 clinical trial assessing duration of androgen receptor pathway inhibitor therapy with androgen deprivation therapy plus metastasis-d…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Micro RNAs to Predict Response to Androgen Deprivation Therapy
A completed clinical trial evaluated microRNA biomarkers to predict response to androgen deprivation therapy in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: MRI Guided Transurethral HIFU for Various Prostate Diseases [NA]
Completed clinical trial evaluating MRI-guided transurethral high-intensity focused ultrasound for various prostate diseases, including loca…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: The Performance of MRI Prostate in Men With Different Prostate Health Index (Phi) Values
A completed clinical trial evaluating the diagnostic performance of MRI prostate imaging across different Prostate Health Index (Phi) values…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Infective Complications in TP Biopsy Without Antibiotic Prophylaxis [NA]
A recruiting study from the Chinese University of Hong Kong is evaluating infectious complications during transperineal prostate biopsy with…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: MRI Prostate for Chinese Men Being Screened for Prostate Cancer
Clinical trial update describing the use of MRI for prostate cancer screening in Chinese men; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients [Phase 1, Phase 2]
This Clinical Trial Update reports on a completed Phase 1/2 study of MDV3100 (enzalutamide) in prostate cancer to evaluate safety, tolerabil…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients
Astellas Pharma Korea conducted a non-interventional study to establish consensus on how to manage metastatic hormone-sensitive prostate can…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study
This completed DECIDER trial evaluated patient preferences for prostate cancer treatment attributes using a survey-based discrete choice exp…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy [Phase 2]
Phase 2 study updating safety observations of enzalutamide in men with progressive castration-resistant prostate cancer previously treated w…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer [Phase 1]
This Phase 1 trial evaluated how multiple doses of enzalutamide affect the pharmacokinetics of digoxin and rosuvastatin, substrates of P-gly…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial [NA]
A completed randomized controlled trial comparing MRI AI-assisted cognitive targeted biopsy (MRI AI-cTB) to routine cognitive targeted biops…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the safety and diagnostic performance of uPAR PET imaging in localized, untr…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
This is an observational cohort study update for castration-resistant prostate cancer, including metastatic cases, registered as NCT02380274…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases [Phase 2]
Phase 2 trial evaluating adjuvant apalutamide with androgen deprivation therapy after radical prostatectomy in men with non-metastatic, high…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy
This clinical trial update reports a completed pilot cohort study using Rubidium-82 myocardial PET imaging to evaluate coronary microvascula…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project [Phase 2]
Phase 2 ASCAPE project trial using artificial intelligence to support breast and prostate cancer patients across Europe; currently active bu…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: The Impact of Radiotherapy on Oligometastatic Cancer
An ongoing clinical trial is evaluating the impact of radiotherapy on oligometastatic cancer. Recruitment is currently underway across multi…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Exercise as Medicine for People With Cancer Sweden [NA]
A Swedish trial by Karolinska Institutet evaluating exercise as medicine for cancer has completed; it includes prostate cancer, breast cance…